메뉴 건너뛰기




Volumn 28, Issue 3, 2010, Pages 424-433

Agreement between multi-dimensional and renal-specific response criteria in patients with juvenile systemic lupus erythematosus and renal disease

Author keywords

Core set; Disease activity; Juvenile systemic lupus erythematosus; Response to therapy

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; BIOLOGICAL MARKER;

EID: 77957002526     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (55)
  • 1
    • 34447327210 scopus 로고    scopus 로고
    • Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis
    • Oxford
    • ILLEI GG, YARBORO CH, KUROIWA T et al.: Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis. Rheumatology (Oxford) 2007; 46: 952-6.
    • (2007) Rheumatology , vol.46 , pp. 952-956
    • Illei, G.G.1    Yarboro, C.H.2    Kuroiwa, T.3
  • 2
    • 33947114890 scopus 로고    scopus 로고
    • Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis
    • GROOTSCHOLTEN C, BAJEMA IM, FLORQUIN S et al.: Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis Rheum 2007; 56: 924-37.
    • (2007) Arthritis Rheum , vol.56 , pp. 924-937
    • Grootscholten, C.1    Bajema, I.M.2    Florquin, S.3
  • 3
    • 33747880632 scopus 로고    scopus 로고
    • Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis
    • BACA V, CATALAN T, VILLASIS-KEEVER M, RAMON G, MORALES AM, RODRIGUEZ-LEYVA F: Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis. Lupus 2006; 15: 490-5.
    • (2006) Lupus , vol.15 , pp. 490-495
    • Baca, V.1    Catalan, T.2    Villasis-Keever, M.3    Ramon, G.4    Morales, A.M.5    Rodriguez-Leyva, F.6
  • 4
    • 28144433147 scopus 로고    scopus 로고
    • Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
    • GINZLER EM, DOOLEY MA, ARANOW C et al.: Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353: 2219-28.
    • (2005) N Engl J Med , vol.353 , pp. 2219-2228
    • Ginzler, E.M.1    Dooley, M.A.2    Aranow, C.3
  • 5
    • 20444466207 scopus 로고    scopus 로고
    • Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
    • CHAN TM, TSE KC, TANG CS, MOK MY, LI FK: Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 2005; 16: 1076-84.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1076-1084
    • Chan, T.M.1    Tse, K.C.2    Tang, C.S.3    Mok, M.Y.4    Li, F.K.5
  • 6
    • 1442355581 scopus 로고    scopus 로고
    • Sequential therapies for proliferative lupus nephritis
    • CONTRERAS G, PARDO V, LECLERCQ B et al.: Sequential therapies for proliferative lupus nephritis. N Engl J Med 2004; 350: 971-80.
    • (2004) N Engl J Med , vol.350 , pp. 971-980
    • Contreras, G.1    Pardo, V.2    Leclercq, B.3
  • 7
    • 0035928643 scopus 로고    scopus 로고
    • Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
    • ILLEI GG, AUSTIN HA, III, CRANE M et al.: Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med 2001; 135: 248-57.
    • (2001) Ann Intern Med , vol.135 , pp. 248-257
    • Illei, G.G.1    Austin III, H.A.2    Crane, M.3
  • 8
    • 0034687429 scopus 로고    scopus 로고
    • Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    • CHAN TM, LI FK, TANG CSO et al.: Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 2000; 343: 1156-62.
    • (2000) N Engl J Med , vol.343 , pp. 1156-1162
    • Chan, T.M.1    Li, F.K.2    Tang, C.S.O.3
  • 9
    • 0030268581 scopus 로고    scopus 로고
    • Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
    • GOURLEY MF, AUSTIN HA, III, SCOTT D et al.: Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med 1996; 125: 549-57.
    • (1996) Ann Intern Med , vol.125 , pp. 549-557
    • Gourley, M.F.1    Austin III, H.A.2    Scott, D.3
  • 10
    • 0036673864 scopus 로고    scopus 로고
    • Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
    • HOUSSIAU FA, VASCONCELOS C, D'CRUZ D et al.: Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 2002; 46: 2121-31.
    • (2002) Arthritis Rheum , vol.46 , pp. 2121-2131
    • Houssiau, F.A.1    Vasconcelos, C.2    D'Cruz, D.3
  • 11
    • 10444275010 scopus 로고    scopus 로고
    • Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial - Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial
    • HOUSSIAU FA, VASCONCELOS C, D'CRUZ D et al.: Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial - Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 2004; 50: 3934-40.
    • (2004) Arthritis Rheum , vol.50 , pp. 3934-3940
    • Houssiau, F.A.1    Vasconcelos, C.2    D'Cruz, D.3
  • 13
    • 0026767866 scopus 로고
    • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
    • BOUMPAS DT, AUSTIN III HA, VAUGHN EM et al.: Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992; 340: 741-5.
    • (1992) Lancet , vol.340 , pp. 741-745
    • Boumpas, D.T.1    Austin III, H.A.2    Vaughn, E.M.3
  • 14
    • 32444443319 scopus 로고    scopus 로고
    • The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
    • RENAL DISEASE SUBCOMMITTEE OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON SYSTEMIC LUPUS ERYTHEMATOSUS RESPONSE CRITERIA
    • RENAL DISEASE SUBCOMMITTEE OF THE AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON SYSTEMIC LUPUS ERYTHEMATOSUS RESPONSE CRITERIA: The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006; 54: 421-32.
    • (2006) Arthritis Rheum , vol.54 , pp. 421-432
  • 15
    • 36448981035 scopus 로고    scopus 로고
    • Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE)
    • MOSCA M, BOMBARDIERI S: Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol 2007; 25 (Suppl. 47): S107-S13.
    • (2007) Clin Exp Rheumatol , vol.25 , Issue.SUPPL. 47
    • Mosca, M.1    Bombardieri, S.2
  • 16
    • 45349102050 scopus 로고    scopus 로고
    • Systemic lupus international collaborating clinics renal activity/response exercise: Development of a renal activity score and renal response index
    • PETRI M, KASITANON N, LEE SS et al.: Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum 2008; 58: 1784-8.
    • (2008) Arthritis Rheum , vol.58 , pp. 1784-1788
    • Petri, M.1    Kasitanon, N.2    Lee, S.S.3
  • 17
    • 45349106761 scopus 로고    scopus 로고
    • Systemic lupus international collaborating clinics renal activity/response exercise: Comparison of agreement in rating renal response
    • PETRI M, KASITANON N, SINGH S et al.: Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum 2008; 58: 1789-95.
    • (2008) Arthritis Rheum , vol.58 , pp. 1789-1795
    • Petri, M.1    Kasitanon, N.2    Singh, S.3
  • 18
    • 4344638042 scopus 로고    scopus 로고
    • International research networks in pediatric rheumatology: The PRINTO perspective
    • RUPERTO N, MARTINI A: International research networks in pediatric rheumatology: the PRINTO perspective. Curr Opin Rheumatol 2004; 16: 566-70.
    • (2004) Curr Opin Rheumatol , vol.16 , pp. 566-570
    • Ruperto, N.1    Martini, A.2
  • 19
    • 3142718093 scopus 로고    scopus 로고
    • Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis
    • Oxford
    • RUPERTO N, RAVELLI A, MURRAY KJ et al.: Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003; 42: 1452-9.
    • (2003) Rheumatology , vol.42 , pp. 1452-1459
    • Ruperto, N.1    Ravelli, A.2    Murray, K.J.3
  • 20
    • 25444439493 scopus 로고    scopus 로고
    • The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set
    • RUPERTO N, RAVELLI A, CUTTICA R et al.: The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set. Arthritis Rheum 2005; 52: 2854-64.
    • (2005) Arthritis Rheum , vol.52 , pp. 2854-2864
    • Ruperto, N.1    Ravelli, A.2    Cuttica, R.3
  • 21
    • 33745074716 scopus 로고    scopus 로고
    • The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement
    • RUPERTO N, RAVELLI A, OLIVEIRA S et al.: The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus. Prospective validation of the definition of improvement. Arthritis Rheum 2006; 55: 355-63.
    • (2006) Arthritis Rheum , vol.55 , pp. 355-363
    • Ruperto, N.1    Ravelli, A.2    Oliveira, S.3
  • 22
    • 39749130953 scopus 로고    scopus 로고
    • Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
    • BRUNNER HI, GLADMAN DD, IBANEZ D, UROWITZ MD, SILVERMAN ED: Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58: 556-62.
    • (2008) Arthritis Rheum , vol.58 , pp. 556-562
    • Brunner, H.I.1    Gladman, D.D.2    Ibanez, D.3    Urowitz, M.D.4    Silverman, E.D.5
  • 23
    • 43249093139 scopus 로고    scopus 로고
    • Adolescent onset of lupus results in more aggressive disease and worse outcomes: Results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
    • TUCKER LB, URIBE AG, FERNANDEZ M et al.: Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 2008; 17: 314-22.
    • (2008) Lupus , vol.17 , pp. 314-322
    • Tucker, L.B.1    Uribe, A.G.2    Fernandez, M.3
  • 24
    • 67651154538 scopus 로고    scopus 로고
    • Causes of death in pediatric systemic lupus erythematosus
    • KLEIN A, CIMAZ R, QUARTIER P et al.: Causes of death in pediatric systemic lupus erythematosus. Clin Exp Rheumatol 2009; 27: 538-9.
    • (2009) Clin Exp Rheumatol , vol.27 , pp. 538-539
    • Klein, A.1    Cimaz, R.2    Quartier, P.3
  • 25
    • 0029044362 scopus 로고
    • American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis
    • FELSON DT, ANDERSON JJ, BOERS M et al.: American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
    • (1995) Arthritis Rheum , vol.38 , pp. 727-735
    • Felson, D.T.1    Anderson, J.J.2    Boers, M.3
  • 27
    • 15444352940 scopus 로고    scopus 로고
    • Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate
    • RUPERTO N, RAVELLI A, FALCINI F et al.: Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Ann Rheum Dis 1998; 57: 38-41.
    • (1998) Ann Rheum Dis , vol.57 , pp. 38-41
    • Ruperto, N.1    Ravelli, A.2    Falcini, F.3
  • 28
    • 3142680150 scopus 로고    scopus 로고
    • International consensus on preliminary definitions of improvement in adult and juvenile myositis
    • RIDER LG, GIANNINI EH, BRUNNER HI et al.: International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004; 50: 2281-90.
    • (2004) Arthritis Rheum , vol.50 , pp. 2281-2290
    • Rider, L.G.1    Giannini, E.H.2    Brunner, H.I.3
  • 29
    • 38649141175 scopus 로고    scopus 로고
    • The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective validation study
    • RUPERTO N, RAVELLI A, PISTORIO A et al.: The provisional Pediatric Rheumatology International Trial Organization/American College of Rheumatology/European League Against Rheumatism disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Rheum 2008; 59: 4-13.
    • (2008) Arthritis Rheum , vol.59 , pp. 4-13
    • Ruperto, N.1    Ravelli, A.2    Pistorio, A.3
  • 30
    • 0020436689 scopus 로고
    • The 1982 revised criteria for the classification of systemic lupus erythematosus
    • TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
    • (1982) Arthritis Rheum , vol.25 , pp. 1271-1277
    • Tan, E.M.1    Cohen, A.S.2    Fries, J.F.3
  • 31
    • 0031229830 scopus 로고    scopus 로고
    • Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
    • HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
    • (1997) Arthritis Rheum , vol.40 , pp. 1725
    • Hochberg, M.C.1
  • 32
    • 33744824094 scopus 로고    scopus 로고
    • Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology?
    • Carlton
    • LANE C, BROWN M, DUNSMUIR W, KELLY J, MANGOS G: Can spot urine protein/creatinine ratio replace 24 h urine protein in usual clinical nephrology? Nephrology (Carlton) 2006; 11: 245-9.
    • (2006) Nephrology , vol.11 , pp. 245-249
    • Lane, C.1    Brown, M.2    Dunsmuir, W.3    Kelly, J.4    Mangos, G.5
  • 33
    • 34047139485 scopus 로고    scopus 로고
    • Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis
    • Oxford
    • LEUNG YY, SZETO CC, TAM LS et al.: Urine protein-to-creatinine ratio in an untimed urine collection is a reliable measure of proteinuria in lupus nephritis. Rheumatology (Oxford) 2007; 46: 649-52.
    • (2007) Rheumatology , vol.46 , pp. 649-652
    • Leung, Y.Y.1    Szeto, C.C.2    Tam, L.S.3
  • 34
    • 0026777352 scopus 로고
    • Derivation of the SLEDAI. A disease activity index for lupus patients
    • The Committee on Prognosis Studies in SLE
    • BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
    • (1992) Arthritis Rheum , vol.35 , pp. 630-640
    • Bombardier, C.1    Gladman, D.D.2    Urowitz, M.B.3    Caron, D.4    Chang, C.H.5
  • 35
    • 0024419180 scopus 로고
    • Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
    • LIANG MH, SOCHER SA, LARSON MG, SCHUR PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.
    • (1989) Arthritis Rheum , vol.32 , pp. 1107-1118
    • Liang, M.H.1    Socher, S.A.2    Larson, M.G.3    Schur, P.H.4
  • 36
    • 0026728050 scopus 로고
    • Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score
    • VITALI C, BENCIVELLI W, ISENBERG DA et al.: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-7.
    • (1992) Clin Exp Rheumatol , vol.10 , pp. 541-547
    • Vitali, C.1    Bencivelli, W.2    Isenberg, D.A.3
  • 37
    • 0032932508 scopus 로고    scopus 로고
    • Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus
    • VITALI C, BENCIVELLI W, MOSCA M, CARRAI P, SERENI M, BOMBARDIERI S: Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. J Rheumatol 1999; 26: 498-501.
    • (1999) J Rheumatol , vol.26 , pp. 498-501
    • Vitali, C.1    Bencivelli, W.2    Mosca, M.3    Carrai, P.4    Sereni, M.5    Bombardieri, S.6
  • 38
    • 0033508774 scopus 로고    scopus 로고
    • Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus
    • BRUNNER HI, FELDMAN BM, BOMBARDIER C, SILVERMAN ED: Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999; 42: 1354-60.
    • (1999) Arthritis Rheum , vol.42 , pp. 1354-1360
    • Brunner, H.I.1    Feldman, B.M.2    Bombardier, C.3    Silverman, E.D.4
  • 39
    • 3442901072 scopus 로고    scopus 로고
    • The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents
    • th Report): 555-76.
    • (2004) Pediatrics , vol.114 , Issue.2 SUPPL. 4TH REPORT , pp. 555-576
  • 40
    • 1642502319 scopus 로고    scopus 로고
    • National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • LEVEY AS, CORESH J, BALK E et al.: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-47.
    • (2003) Ann Intern Med , vol.139 , pp. 137-147
    • Levey, A.S.1    Coresh, J.2    Balk, E.3
  • 41
    • 4143078383 scopus 로고    scopus 로고
    • Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology
    • RUPERTO N, RAVELLI A, PISTORIO A et al.: Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol 2001; 19: S1-S9.
    • (2001) Clin Exp Rheumatol , vol.19
    • Ruperto, N.1    Ravelli, A.2    Pistorio, A.3
  • 42
    • 0003533032 scopus 로고    scopus 로고
    • First Edition. ed., Boston, MA, USA, The Health Institute, New England Medical Center
    • LANDGRAF JM, ABETZ L, WARE JE: The CHQ User's Manual. First Edition. ed., Boston, MA, USA, The Health Institute, New England Medical Center, 1996.
    • (1996) The CHQ User's Manual
    • Landgraf, J.M.1    Abetz, L.2    Ware, J.E.3
  • 43
    • 0033951554 scopus 로고    scopus 로고
    • The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison
    • GLADMAN DD, GOLDSMITH CH, UROWITZ MB et al.: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 2000; 27: 373-6.
    • (2000) J Rheumatol , vol.27 , pp. 373-376
    • Gladman, D.D.1    Goldsmith, C.H.2    Urowitz, M.B.3
  • 44
    • 0025454512 scopus 로고
    • Comparisons of five health status instruments for orthopedic evaluation
    • LIANG MH, FOSSEL AH, LARSON MG: Comparisons of five health status instruments for orthopedic evaluation. Med Care 1990; 28: 632-42.
    • (1990) Med Care , vol.28 , pp. 632-642
    • Liang, M.H.1    Fossel, A.H.2    Larson, M.G.3
  • 46
    • 0021998049 scopus 로고
    • Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research
    • LIANG MH, LARSON MG, CULLEN KE, SCHWARTZ JA: Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum 1985; 28: 542-7.
    • (1985) Arthritis Rheum , vol.28 , pp. 542-547
    • Liang, M.H.1    Larson, M.G.2    Cullen, K.E.3    Schwartz, J.A.4
  • 47
    • 0029064207 scopus 로고
    • Evaluating measurement responsiveness
    • LIANG MH: Evaluating measurement responsiveness. J Rheumatol 1995; 22: 1191-2.
    • (1995) J Rheumatol , vol.22 , pp. 1191-1192
    • Liang, M.H.1
  • 48
    • 84973587732 scopus 로고
    • A coefficient of agreement for nominal scales
    • COHEN J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960; 20: 37-46.
    • (1960) Educ Psychol Meas , vol.20 , pp. 37-46
    • Cohen, J.1
  • 50
    • 0017360990 scopus 로고
    • The measurement of observer agreement for categorical data
    • LANDIS JR, KOCH GC: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
    • (1977) Biometrics , vol.33 , pp. 159-174
    • Landis, J.R.1    Koch, G.C.2
  • 51
    • 0022578857 scopus 로고
    • Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs
    • AUSTIN HA, KLIPPEL JH, BALOW JE et al.: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986; 314: 614-9.
    • (1986) N Engl J Med , vol.314 , pp. 614-619
    • Austin, H.A.1    Klippel, J.H.2    Balow, J.E.3
  • 52
    • 11144356023 scopus 로고    scopus 로고
    • EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis
    • YEE CS, GORDON C, DOSTAL C et al.: EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Ann Rheum Dis 2004; 63: 525-9.
    • (2004) Ann Rheum Dis , vol.63 , pp. 525-529
    • Yee, C.S.1    Gordon, C.2    Dostal, C.3
  • 53
    • 1642480050 scopus 로고    scopus 로고
    • The classification of glomerulonephritis in systemic lupus erythematosus revisited
    • WEENING JJ, D'AGATI VD, SCHWARTZ MM et al.: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-30.
    • (2004) Kidney Int , vol.65 , pp. 521-530
    • Weening, J.J.1    D'Agati, V.D.2    Schwartz, M.M.3
  • 54
    • 0032416213 scopus 로고    scopus 로고
    • Outcome criteria for lupus nephritis trials: A critical overview
    • BOUMPAS DT, BALOW JE: Outcome criteria for lupus nephritis trials: a critical overview. Lupus 1998; 7: 622-9.
    • (1998) Lupus , vol.7 , pp. 622-629
    • Boumpas, D.T.1    Balow, J.E.2
  • 55
    • 34447518980 scopus 로고    scopus 로고
    • Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide
    • UROWITZ MB, IBANEZ D, ALI Y, GLADMAN DD: Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide. J Rheumatol 2007; 34: 1491-6.
    • (2007) J Rheumatol , vol.34 , pp. 1491-1496
    • Urowitz, M.B.1    Ibanez, D.2    Ali, Y.3    Gladman, D.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.